Intralipid and In Vitro Fertilization (IVF)

What is Intralipid?

The success of in vitro fertilization (IVF) depends on multiple and often complex factors, one of which is the woman’s immune system. In recent years, reproductive medicine has increasingly focused on the role of immunological factors in fertility, embryo implantation, and the healthy progression of pregnancy.

Intralipid therapy is an immunomodulatory approach used in certain assisted reproduction cases, aiming to create a more favorable immune environment within the endometrium. Intralipid is an intravenous lipid emulsion that has long been used in clinical medicine for parenteral nutrition but has also gained a role in reproductive medicine due to its potential immunomodulatory effects.

More specifically, the treatment aims to reduce the overactivity of natural killer (NK) cells and promote a more balanced immune response, which may be important for successful embryo implantation and early pregnancy development.

The use of Intralipid is typically considered in women with a history of recurrent implantation failure or recurrent pregnancy loss, as well as in cases where immunological factors are suspected to interfere with the implantation process. The therapy is administered intravenously at specific stages of an IVF cycle, with the goal of supporting a more stable and receptive immunological environment for embryo implantation and the progression of pregnancy.

Composition and mode of action

Intralipid is a white, milky solution made primarily from plant-based fat particles, specifically soybean oil, egg lecithin, glycerin, and water for injection. The solution is high in polyunsaturated fatty acids, which play a significant role in regulating the body's inflammatory and immune responses.When administered intravenously, Intralipid gradually alters the cellular activity of the immune system, particularly leukocytes and NK cells. It may also affect the metabolism of prostaglandins and cytokines — molecules directly involved in inflammation, immune activation, and angiogenesis, all critical processes for fertilization and embryo implantation.

How Intralipid affects the immune system

Intralipid works by regulating the immune system’s overactivity, which may be observed in women with unexplained infertility, recurrent miscarriages, or implantation failures, even after transferring high-quality embryos. Its mechanism is linked to reducing the cytotoxic activity of NK cells, which normally play a defensive role but, when overactive, may perceive the embryo as a “foreign body” and attack it.By suppressing the excessive activation of these cells and generally balancing immune parameters, Intralipid contributes to the creation of a friendly intrauterine environment that allows for successful implantation and continuation of pregnancy. The treatment may also positively influence the balance between Th1 and Th2 lymphocytes, which is associated with the maternal immune tolerance of the embryo.

When Is Intralipid Used in IVF

Intralipid therapy is not used in all IVF cases but is a specialized approach applied mainly when there are indications that the woman’s immune system is hindering successful implantation or pregnancy progression. The precise timing and therapeutic protocol are determined based on the clinical picture, laboratory results, and patient history.

Cases where Intralipid therapy is recommended

Intralipid therapy is mainly recommended for couples who have undergone IVF or other assisted reproduction treatments without achieving a healthy pregnancy. The addition of Intralipid may be considered in cases such as:

Recurrent implantation failure (RIF)

Repeated first-trimester miscarriages, particularly when no other clear cause has been identified

Unexplained infertility, when no obvious cause is found but an immunological contribution is suspected

Confirmed high NK cell activity or abnormal Th1/Th2 ratio

Recurrent biochemical pregnancies

A fertility specialist will evaluate the couple’s medical history and diagnostic findings in order to determine whether the addition of Intralipid therapy may help improve implantation and support the healthy progression of pregnancy.

Combination with other treatments

Intralipid therapy can be incorporated into different assisted reproduction treatment protocols, most commonly in IVF/ICSI cycles. In many cases, the first infusion is administered a few days before embryo transfer, with the possibility of repeating the treatment after implantation if the pregnancy test is positive, depending on the patient’s immunological profile.

Intralipid therapy may also be combined with preimplantation genetic testing (PGT-A / PGT-M), hormonal support, or intrauterine insemination (IUI) in women with immunological factors affecting fertility, although the available clinical data are more established for IVF cycles.

In certain cases, the treatment may also be used in natural conception cycles when a significant immunological imbalance has been diagnosed. The correct timing and integration of Intralipid therapy with other treatments require clinical expertise and an individualized treatment plan, as each fertility case is unique.

Do you have a history of failed IVF attempts or miscarriages?

Request a specialized immunological assessment and personalized consultation from our scientific team.

Book a Consultation

Benefits of Intralipid Therapy

The addition of Intralipid therapy to an IVF treatment protocol may offer significant benefits for women with diagnosed immunological imbalance. This therapy does not act merely as supportive treatment but targets one of the key mechanisms that may negatively affect embryo implantation and the progression of pregnancy. The potential clinical benefits of Intralipid therapy can be summarized in three main areas:

Improved implantation rates

One of the main advantages of Intralipid therapy is the potential improvement in embryo implantation rates. In IVF cycles where good-quality embryos are available but repeated implantation failures occur, immunological factors may play an important role.

The administration of Intralipid may help reduce the activity of aggressive immune cells, such as natural killer (NK) cells, and improve endometrial receptivity, making the uterine environment more supportive for embryo implantation. As a result, the chances of success may increase, particularly in women who have undergone multiple IVF attempts without achieving pregnancy.

Microscopic view of IVF egg injection, illustrating precise technique used in immunological fertility treatment.

Reduced miscarriages

Another important potential benefit of Intralipid therapy is the reduction in the risk of miscarriage, particularly in women with a history of recurrent first-trimester pregnancy loss without a clear cause.

In some cases, autoimmune reactions against the embryo due to immune system dysregulation may lead to pregnancy loss even after successful implantation. Intralipid may help regulate these immune responses, reducing the potential toxicity of the uterine environment and allowing the embryo to develop more normally during the critical early stages of pregnancy.

Happy couple proudly displays their IVF ultrasound, celebrating successful conception after immunological treatment.

Better immunological balance in the uterus

The success of pregnancy depends to a large extent on immunological balance within the endometrial environment, meaning the harmonious interaction between the maternal immune system and the developing embryo.

Intralipid may contribute to restoring this balance by reducing the overactivity of Th1 immune responses and supporting Th2 responses, which are considered more favorable for pregnancy maintenance. In addition, it may support angiogenesis and microcirculation within the endometrium, improving the nutritional support of the embryo.

Medical model demonstrating IVF procedure, highlighting how intralipid therapy supports reproductive success.

Intralipid Treatment Timeline

Intralipid therapy is incorporated into the IVF protocol as a specialized immune-regulating tool. Proper timing, duration, and location of administration are critical to its effectiveness. Below is a step-by-step breakdown of the procedure.

When the infusion is done (before and after embryo transfer)

The first Intralipid infusion is usually administered a few days before embryo transfer in order to reduce the overactivity of the immune system and prepare the endometrium for implantation. More specifically, the intravenous infusion is typically given approximately 5 to 7 days before embryo transfer.

Depending on the results of immunological tests and the progression of the pregnancy, a second Intralipid infusion may be administered after a positive beta-hCG pregnancy test, usually between the 4th and 6th week of pregnancy, in order to further stabilize the immunological environment of the uterus.

In special cases with significantly elevated immunological markers (for example very high NK cell levels), a third infusion may be administered during the early weeks of pregnancy, or the treatment may continue during the first trimester, always under the guidance of a specialized reproductive medicine physician.

How Long the Infusion Takes & Where It Is Performed

Intralipid is administered intravenously under medical supervision. The infusion procedure usually lasts approximately 60 minutes, and the patient is required to remain in a comfortable resting position during administration.

The treatment is provided in:

IVF units offering immunological support

Specialized clinics experienced in assisted reproduction

Private practices or partner diagnostic centers equipped for IV infusions

The Fertulity team ensures the coordinated scheduling of treatment to integrate smoothly into the overall IVF protocol without delays or inconvenience.

Are there side effects?

Intralipid therapy is considered safe, with a very low incidence of side effects, especially when administered under expert medical supervision. Most women experience no discomfort during or after infusion.

Possible mild side effects include:

Mild fluid retention or swelling in the limbs

Fatigue on the day of infusion

Rarely, allergic reactions (particularly in individuals with allergies to soy, nuts, or egg products)

Before starting the therapy, a detailed medical history is always taken to rule out contraindications and ensure complete safety.

Want to know if Intralipid therapy is right for you?

Our team of specialized gynecologists is ready to review your history and design a treatment plan tailored to your needs.

Discuss Your Plan with a Fertility Specialist

Frequently Asked Questions About Intralipid Therapy in IVF

Can Intralipid therapy be applied in natural conception cycles?

Yes, in certain cases Intralipid therapy can be applied even outside IVF, in natural conception cycles. This applies mainly to women with confirmed immune problems or a history of recurrent miscarriages. The therapy may help regulate the immune system and enhance natural implantation, but its use requires careful assessment by a specialized doctor.

Is special preparation needed before Intralipid infusion?

No special preparation is required before the Intralipid infusion, although fasting for a few hours or following doctor’s instructions may be recommended. Allergy screening (e.g., for soy or egg) is also performed, and it’s best to avoid intense physical activity on the day of treatment. Your physician may request a blood test a few days prior to evaluate your general health status.

Is there scientific evidence supporting Intralipid’s effectiveness?

Yes, there are scientific studies and publications documenting Intralipid’s immunomodulatory action and its potential positive effect on IVF success. However, the therapy is not a cure-all, and its effectiveness depends on proper patient selection. Fertulity’s trusted physicians rely on the latest research data to integrate Intralipid into IVF protocols only when strong indications are present.

Can Intralipid Therapy Be Combined with Corticosteroids or Other Immunotherapies?

In certain cases, Intralipid therapy may be combined with intrauterine PRP infusion, anticoagulant medication, or other forms of immunomodulatory treatment, such as intravenous immunoglobulin (IVIG). The purpose of these combinations is to provide additional support for embryo implantation, particularly in patients with a complex immunological profile.

The design of the treatment protocol is always individualized and requires careful coordination with the treating fertility specialist and reproductive endocrinologist, who will determine the most appropriate therapeutic approach based on the patient’s medical history and diagnostic findings.

Our Doctors

In an era where fertility requires knowledge, care, and substantial guidance, FertUlity is not an impersonal clinic. It is two people who look you in the eye and accompany you step by step on the journey you dream of.

Dr. Maria Oikonomou Obstetrician – Gynecologist

See Full CV

Dr. Chrysostomos (Makis) Papadopoulos Obstetrician – Gynecologist, MD, PhDc, MIC I

See Full CV

The First Step Starts Now

You don’t need to have all the answers to begin.
All it takes is one first step, and a team that truly listens.

Book Your Consultation

FertulityThrough the Words of Parents

100% genuine, public Google reviews.
Because every fertility journey begins with honesty and trust.

Why choose FertUlity?

Because every fertility journey deserves the right support.

At FertUlity, we provide science-based fertility care with a human approach.
We support every path, from fertility assessment and preservation to modern assisted reproduction.